Article citationsMore >>

Leung VK, Loke TK, Luk IS, Ng WL, Chau TN, Law ST, Chan JC. Nodular regenerative hyperplasia of the liver associated with systemic lupus erythematosus: three cases. Hong Kong Med J. 2009 Apr;15(2):139-42.

has been cited by the following article:

Article

Pulmonary Hypertension in a Patient with Non-cirrhotic Portal Hypertension and Scleroderma Sine Scleroderma: A Case Report

1Division of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, Saint Louis University School of Medicine, St Louis, MO, United States

2Department of Internal Medicine, Saint Louis University School of Medicine, St Louis, MO, United States

3Department of Pathology, Saint Louis University School of Medicine, St Louis, MO, United States

4Division of Rheumatology, Department of Internal Medicine, Saint Louis University School of Medicine, St Louis, MO, United States


American Journal of Medical Case Reports. 2016, Vol. 4 No. 5, 170-172
DOI: 10.12691/ajmcr-4-5-7
Copyright © 2016 Science and Education Publishing

Cite this paper:
Ghassan Kamel, Joseph Espiritu, Adrian M. Di Bisceglie, Guilan Chen, Reema Syed, Ravi Nayak. Pulmonary Hypertension in a Patient with Non-cirrhotic Portal Hypertension and Scleroderma Sine Scleroderma: A Case Report. American Journal of Medical Case Reports. 2016; 4(5):170-172. doi: 10.12691/ajmcr-4-5-7.

Correspondence to: Ravi  Nayak, Division of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, Saint Louis University School of Medicine, St Louis, MO, United States. Email: nayakrp@slu.edu

Abstract

Porto-pulmonary hypertension is a known complication of liver cirrhosis but its association with non-cirrhotic portal hypertension patients is rare. We report a case of pulmonary hypertension in a patient with non-cirrhotic portal hypertension and scleroderma sine scleroderma. The two latter conditions have been shown to be independently associated with pulmonary arterial hypertension. DLCO is expected to decrease in scleroderma patients due to pulmonary vascular disease, which will result in an increased FVC/DLCO ratio. The low FVC/DLCO ratio in our patient suggests that pulmonary arterial hypertension was more likely to have been due to non-cirrhotic portal hypertension than scleroderma sine scleroderma.

Keywords